CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
Mohs micrographic surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04015453
NCT04015453N/ACompleted
CompareCT.gov

Correlation of Early Postoperative Scar Appearance With Long-term Scar Outcomes: a Single Academic Institution Study

Abramson Cancer Center at Penn Medicine·observational·Posted Jul 11, 2019·Updated Apr 28, 2020

In Brief

An observational study evaluating Mohs micrographic surgery for Scar and 4 related conditions. Completed, enrolled 113 participants.

Detailed Summary

A retrospective cohort study of early and late period postoperative scars using previously validated survey measures and clinical photographs. The target population consists of participants treated with Mohs micrographic surgery (MMS) for a facial skin cancer by the division of dermatologic surgery. This study aims to determine if patient assessment of scar appearance correlates with physician ratings and/or third-person observer ratings. Secondary goals are to assess for correlations between early post-operative scar appearance and long-term scar appearance as well as identification of predictive factors for scar healing.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsScar, Surgical Wound, Quality of Life, Mohs Micrographic Surgery, Skin Cancer Face
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 11, 2019
Enrollment StartJul 1, 2016
Primary CompletionNov 1, 2016
Study CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.0 years ago

Interventions

Mohs micrographic surgeryprocedure

All participants will have received Mohs micrographic surgical treatment for a facial skin cancer.